MCE - Delayed Quote EUR
Pangaea Oncology, S.A. (PANG.MC)
1.7300
0.0000
(0.00%)
At close: May 16 at 12:00:01 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,998.3560
7,998.3560
4,367.7700
4,603.1460
4,099.5090
Cost of Revenue
244.8590
244.8590
255.5390
-568.6130
-512.7210
Gross Profit
7,753.4970
7,753.4970
4,112.2310
5,171.7590
4,612.2300
Operating Expense
10,497.1740
10,497.1740
6,309.7540
5,469.2270
6,160.6870
Operating Income
-2,743.6770
-2,743.6770
-2,197.5230
-297.4680
-1,548.4570
Net Non Operating Interest Income Expense
-216.1230
-216.1230
-276.1920
-378.6660
-259.8050
Pretax Income
-3,506.5210
-3,506.5210
-2,838.9050
-1,098.4130
-1,864.9120
Tax Provision
1,286.7090
1,286.7090
-114.7130
-456.5060
-112.6840
Net Income Common Stockholders
-4,656.3980
-4,656.3980
-2,712.1290
-641.9070
-1,752.2280
Diluted NI Available to Com Stockholders
-4,656.3980
-4,656.3980
-2,712.1290
-641.9070
-1,752.2280
Basic EPS
-0.15
--
-0.09
-0.03
-0.09
Diluted EPS
-0.15
--
-0.09
-0.03
-0.09
Basic Average Shares
30,144.6210
--
30,443.8190
22,816.9630
19,000.7940
Diluted Average Shares
30,144.6210
--
30,443.8190
22,816.9630
19,000.7940
Total Operating Income as Reported
--
--
2,558.5090
532.9650
-1,622.2280
Rent Expense Supplemental
343.1010
343.1010
405.5920
356.0180
337.2300
Total Expenses
10,742.0330
10,742.0330
6,565.2930
4,900.6140
5,647.9660
Net Income from Continuing & Discontinued Operation
-4,656.3980
-4,656.3980
-2,712.1290
-641.9070
-1,752.2280
Normalized Income
-4,294.5193
-4,294.5193
-2,506.4806
-477.9008
-1,752.2280
Interest Income
--
--
19.7340
1.8970
0
Interest Expense
133.9430
133.9430
189.4120
252.9100
186.0340
Net Interest Income
-216.1230
-216.1230
-276.1920
-378.6660
-259.8050
EBIT
-3,372.5780
-3,372.5780
-2,649.4930
-845.5030
-1,678.8780
EBITDA
-1,557.3120
-1,557.3120
-1,408.8170
146.7800
730.3110
Reconciled Cost of Revenue
244.8590
244.8590
255.5390
-568.6130
-512.7210
Reconciled Depreciation
1,815.2660
1,815.2660
1,240.6760
992.2830
2,409.1890
Net Income from Continuing Operation Net Minority Interest
-4,656.3980
-4,656.3980
-2,712.1290
-641.9070
-1,752.2280
Total Unusual Items Excluding Goodwill
-482.5050
-482.5050
-214.3080
-218.6750
0
Total Unusual Items
-482.5050
-482.5050
-214.3080
-218.6750
0
Normalized EBITDA
-1,074.8070
-1,074.8070
-1,194.5090
365.4550
730.3110
Tax Rate for Calcs
0.0003
0.0003
0
0.0003
0.0001
Tax Effect of Unusual Items
-120.6263
-120.6263
-8.6596
-54.6688
0
12/31/2020 - 9/19/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade